Picture of Certara logo

CERT — Certara News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapNeutral

Brief: Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy For Potential First-In-Class Cancer Drug

Sept 18 (Reuters) - Certara Inc  CERT.O :
    * CERTARA & ICHNOS GLENMARK INNOVATION COLLABORATION
OPTIMIZES
DOSING STRATEGY FOR POTENTIAL FIRST-IN-CLASS CANCER DRUG

Source text for Eikon:  ID:nGNX7kl2Jv 
Further company coverage:  CERT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Certara

See all news